Browse Data and Analysis

The push for the move toward biotechnology in Cote d'Ivoire began in June of 2015, when the government of Cote d'Ivoire (GOCI) adopted and ratified the Cartagena Protocol.

On July 26, 2016, Cote d’Ivoire announced the implementation of the national biosafety law after its adoption by parliament. Although the country is in the early stages of adopting agricultural biotechnology, its biosafety law is the foundation on which the country will manage the approval processes, risk management, containment, and labelling for genetically engineered (GE) products developed domestically or by a third country.

While still in the early stages for adopting genetically engineered products, the Government of Cote d’Ivoire is putting systems in place to eventually allow GE products onto the market.

The Government of Senegal is reviewing and revising its new biosafety law which may include language for an expedited approval process for certain genetically engineered (GE) products.

The Biosafety Law, 2012 contains information on the biotechnology approval process in Burkina Faso for GE products developed domestically or by a third country.

On July, 26, 2016, The President of Cote d’Ivoire announced the implementation of the national biosafety law adopted by the parliament on July 1, 2016.

Since January 2014, the Burkinabe National Biosafety Agency (NBA) has been converting the status of the organization to a technical and scientific public institution (EPSET) for greater autonomy.